Insider Trades47 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | Buy | GLSI | Snehal Patel | CEO and CFO | 2,200 | $13.43 | $226.8M | -54.69% | +98.59% | $29.6K | +0.02% | — | Trim |
| Jul 27, 2026 | Buy | GLSI | Snehal Patel | CEO and CFO | 1,500 | $13.62 | $226.8M | -54.69% | +98.59% | $20.4K | +0.03% | — | Trim |
| Jul 23, 2026 | Buy | GLSI | Snehal Patel | CEO and CFO | 3,600 | $13.06 | $226.8M | -54.69% | +98.59% | $47.0K | +0.03% | — | Trim |
| Jan 13, 2026 | Buy | GLSI | Snehal Patel | CEO and CFO | 1,800 | $29.83 | $226.8M | -54.69% | +98.59% | $53.7K | +0.03% | — | Trim |
| Jan 12, 2026 | Buy | GLSI | Snehal Patel | CEO and CFO | 2,900 | $27.54 | $226.8M | -54.69% | +98.59% | $79.9K | +0.05% | — | Trim |
| Dec 31, 2025 | Buy | GLSI | Snehal Patel | CEO and CFO | 4,300 | $21.36 | $226.8M | -54.69% | +98.59% | $91.8K | +0.08% | — | Trim |
| Dec 30, 2025 | Buy | GLSI | Snehal Patel | CEO and CFO | 2,900 | $21.73 | $226.8M | -54.69% | +98.59% | $63.0K | +0.05% | — | Trim |
| Dec 18, 2025 | Buy | GLSI | Snehal Patel | CEO and CFO | 4,100 | $12.62 | $226.8M | -54.69% | +98.59% | $51.7K | +0.07% | — | Trim |
| Nov 25, 2025 | Buy | GLSI | Snehal Patel | CEO and CFO | 4,600 | $8.37 | $226.8M | -54.69% | +98.59% | $38.5K | +0.08% | — | Trim |
| Nov 7, 2025 | Buy | GLSI | Snehal Patel | CEO and CFO | 10,600 | $8.43 | $226.8M | -54.69% | +98.59% | $89.4K | +0.19% | — | Trim |
| Oct 31, 2025 | Buy | GLSI | Snehal Patel | CEO and CFO | 2,300 | $9.26 | $226.8M | -54.69% | +98.59% | $21.3K | +0.04% | — | Trim |
| Apr 25, 2025 | Buy | GLSI | Snehal Patel | CEO and CFO | 3,600 | $9.88 | $226.8M | -54.69% | +98.59% | $35.6K | +0.06% | — | Trim |
| Apr 17, 2025 | Buy | GLSI | Snehal Patel | CEO and CFO | 5,400 | $8.98 | $226.8M | -54.69% | +98.59% | $48.5K | +0.10% | — | Trim |
| Apr 7, 2025 | Buy | GLSI | Snehal Patel | CEO and CFO | 3,600 | $9.10 | $226.8M | -54.69% | +98.59% | $32.8K | +0.06% | — | Trim |
| Apr 4, 2025 | Buy | GLSI | Snehal Patel | CEO and CFO | 5,500 | $8.73 | $226.8M | -54.69% | +98.59% | $48.0K | +0.10% | — | Trim |
| Jan 10, 2025 | Buy | GLSI | Snehal Patel | CEO and CFO | 2,500 | $12.51 | $226.8M | -54.69% | +98.59% | $31.3K | +0.05% | — | Trim |
| Jan 6, 2025 | Buy | GLSI | Snehal Patel | CEO and CFO | 2,900 | $13.58 | $226.8M | -54.69% | +98.59% | $39.4K | +0.03% | — | Trim |
| Jan 3, 2025 | Buy | GLSI | Snehal Patel | CEO and CFO | 3,400 | $12.95 | $226.8M | -54.69% | +98.59% | $44.0K | +0.06% | — | Trim |
| Jan 2, 2025 | Buy | GLSI | Snehal Patel | CEO and CFO | 2,000 | $11.97 | $226.8M | -54.69% | +98.59% | $23.9K | +0.04% | — | Trim |
| Dec 31, 2024 | Buy | GLSI | Snehal Patel | CEO and CFO | 2,400 | $11.36 | $226.8M | -54.69% | +98.59% | $27.3K | +0.04% | — | Trim |
| Dec 30, 2024 | Buy | GLSI | Snehal Patel | CEO and CFO | 3,200 | $11.12 | $226.8M | -54.69% | +98.59% | $35.6K | +0.06% | — | Trim |
| Nov 21, 2024 | Buy | GLSI | Jaye Thompson | VP Clinical Reg Affairs | 1,000 | $12.91 | $226.8M | -54.69% | +98.59% | $12.9K | +0.38% | — | Trim |
| Sep 26, 2024 | Buy | GLSI | Snehal Patel | CEO and CFO | 1,500 | $14.63 | $226.8M | -54.69% | +98.59% | $21.9K | +0.03% | — | Trim |
| Aug 12, 2024 | Buy | GLSI | Jaye Thompson | VP Clinical Reg Affairs | 800 | $13.85 | $226.8M | -54.69% | +98.59% | $11.1K | +0.30% | — | Trim |
| Aug 6, 2024 | Buy | GLSI | Snehal Patel | CEO and CFO | 2,000 | $13.81 | $226.8M | -54.69% | +98.59% | $27.6K | +0.04% | — | Trim |
| Aug 5, 2024 | Buy | GLSI | Snehal Patel | CEO and CFO | 5,500 | $13.18 | $226.8M | -54.69% | +98.59% | $72.5K | +0.10% | — | Trim |
| Aug 2, 2024 | Buy | GLSI | Jaye Thompson | VP Clinical Reg Affairs | 1,000 | $15.15 | $226.8M | -54.69% | +98.59% | $15.2K | +0.38% | — | Trim |
| Jul 23, 2024 | Buy | GLSI | Snehal Patel | CEO and CFO | 1,500 | $15.89 | $226.8M | -54.69% | +98.59% | $23.8K | +0.03% | — | Trim |
| Jul 18, 2024 | Buy | GLSI | Jaye Thompson | VP Clinical Reg Affairs | 1,000 | $16.00 | $226.8M | -54.69% | +98.59% | $16.0K | +0.38% | — | Trim |
| Jun 13, 2024 | Buy | GLSI | Snehal Patel | CEO and CFO | 174,825 | $14.30 | $226.8M | -54.69% | +98.59% | $2.5M | +3.27% | — | Trim |
| Apr 1, 2024 | Buy | GLSI | Snehal Patel | CEO and CFO | 3,000 | $19.08 | $226.8M | -54.69% | +98.59% | $57.2K | +0.06% | — | Trim |
| Mar 22, 2024 | Buy | GLSI | Snehal Patel | CEO and CFO | 2,500 | $19.98 | $226.8M | -54.69% | +98.59% | $50.0K | +0.05% | — | Trim |
| Mar 20, 2024 | Buy | GLSI | Snehal Patel | CEO and CFO | 1,500 | $17.68 | $226.8M | -54.69% | +98.59% | $26.5K | +0.03% | — | Trim |
| Mar 5, 2024 | Buy | GLSI | Snehal Patel | CEO and CFO | 3,500 | $12.49 | $226.8M | -54.69% | +98.59% | $43.7K | +0.07% | — | Trim |
| Mar 5, 2024 | Buy | GLSI | Snehal Patel | CEO and CFO | 30,500 | $12.49 | $226.8M | -54.69% | +98.59% | $380.9K | +0.57% | — | Trim |
| Mar 4, 2024 | Buy | GLSI | Snehal Patel | CEO and CFO | 4,100 | $13.03 | $226.8M | -54.69% | +98.59% | $53.4K | +0.08% | — | Trim |
| Feb 16, 2024 | Buy | GLSI | Snehal Patel | CEO and CFO | 10,800 | $11.16 | $226.8M | -54.69% | +98.59% | $120.5K | +0.20% | — | Trim |
| Feb 15, 2024 | Buy | GLSI | Snehal Patel | CEO and CFO | 12,700 | $11.07 | $226.8M | -54.69% | +98.59% | $140.6K | +0.24% | — | Trim |
| Nov 10, 2023 | Buy | GLSI | Snehal Patel | CEO and CFO | 5,000 | $10.17 | $226.8M | -54.69% | +98.59% | $50.8K | +0.09% | — | Trim |
| Nov 3, 2023 | Buy | GLSI | Snehal Patel | CEO and CFO | 3,500 | $9.11 | $226.8M | -54.69% | +98.59% | $31.9K | +0.07% | — | Trim |
| Oct 27, 2023 | Buy | GLSI | Jaye Thompson | VP Clinical Reg Affairs | 500 | $8.57 | $226.8M | -54.69% | +98.59% | $4.3K | +0.19% | — | Trim |
| Oct 26, 2023 | Buy | GLSI | Snehal Patel | CEO and CFO | 2,500 | $7.97 | $226.8M | -54.69% | +98.59% | $19.9K | +0.05% | — | Trim |
| Oct 25, 2023 | Buy | GLSI | Snehal Patel | CEO and CFO | 2,500 | $7.91 | $226.8M | -54.69% | +98.59% | $19.8K | +0.05% | — | Trim |
| Oct 10, 2023 | Buy | GLSI | Snehal Patel | CEO and CFO | 1,000 | $9.07 | $226.8M | -54.69% | +98.59% | $9.1K | +0.02% | — | Trim |
| Oct 4, 2023 | Buy | GLSI | Snehal Patel | CEO and CFO | 2,000 | $8.63 | $226.8M | -54.69% | +98.59% | $17.3K | +0.04% | — | Trim |
| Sep 26, 2023 | Buy | GLSI | Jaye Thompson | VP Clinical Reg Affairs | 600 | $8.71 | $226.8M | -54.69% | +98.59% | $5.2K | +0.23% | — | Trim |
| Sep 19, 2023 | Buy | GLSI | Snehal Patel | CEO and CFO | 4,000 | $8.95 | $226.8M | -54.69% | +98.59% | $35.8K | +0.08% | — | Trim |